英文名稱 | Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) |
---|---|
中文名稱 | 德喜曲妥珠單抗 | 德盧替康-曲妥珠單抗 |
CAS號(hào) | 1826843-81-5 |
儲(chǔ)存條件 | store at -20°C |
規(guī)格 | 庫存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) |
---|---|
中文名稱 | 德喜曲妥珠單抗 | 德盧替康-曲妥珠單抗 |
CAS號(hào) | 1826843-81-5 |
儲(chǔ)存條件 | store at -20°C |
Trastuzumab Deruxtecan (Enhertu) is a HER2-targeting ADC combining a humanized anti-HER2 antibody with a topoisomerase I inhibitor, deruxtecan (DXd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer.
PMID: 33473250 PMCID: PMC7797586 DOI: 10.1177/1758835920986518
Cancer Sci. 2020 Dec;111(12):4636-4645.
PMID: 31574081 PMCID: PMC6772042 DOI: 10.1371/journal.pone.0222280